AkditalCAS:AKT -1.34%84 Net Margin % is 10.76% as of Dec. 2025, which is 27% above its 10-year median of 8.47. GuruFocus rates CAS:AKT with a GF Score™ of 84/100 and a GF Value™ of MAD2,083.49 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Akdital ranks better than 77.54% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Akdital's Net Income for the
six
months ended in Dec. 2025 was MAD250 Mil. Akdital's Revenue for the
six
months ended in Dec. 2025 was MAD2,320 Mil. Therefore, Akdital's net margin for the quarter that ended in Dec. 2025 was 10.76%.
The historical rank and industry rank for Akdital's Net Margin % or its related term are showing as below:
CAS:AKT'
s Net Margin % Range Over the Past 10 Years
Min: 1.29 Med: 8.47 Max: 10.65
Current: 10.05
CAS:AKT's Net Margin % is ranked better than 77.54% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs CAS:AKT: 10.05
Akdital (CAS:AKT) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Akdital Net Margin % Related Terms
Akdital Net Margin % Historical Data
* Premium members only.
The historical data trend for Akdital's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Akdital's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akdital Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Akdital's Net Margin % distribution charts can be found below:
* The bar in red indicates where Akdital's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akdital (CAS:AKT) has a Net Margin % of 10.76% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Akdital and its competitors. This is 27% above median its historical median of 8.47. Over the past decade, Akdital's Net Margin % has ranged from 1.29 to 10.65. According to the industry distribution chart, Akdital ranks #150 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 22.5%.
Is Akdital's Net Margin % too high?
Akdital's current Net Margin % of 10.76% is 27% above median its 10-year median of 8.47. Over the past 10 years, this metric has ranged from a low of 1.29 to a high of 10.65. The Healthcare Providers & Services industry median Net Margin % is 2.89. Akdital's value of 10.76% is 273% above this industry median. Based on the distribution chart, Akdital ranks #150 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Akdital has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Akdital's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Akdital ranks #150 out of 668 companies for Net Margin %. This places Akdital in the top 23% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.89. Akdital's value of 10.76% is 273% above this benchmark. Historically, Akdital's own Net Margin % has ranged from 1.29 to 10.65 over the past decade. While the company's 10-year median is 8.47 vs. the industry median of 2.89, Akdital has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Akdital's current Net Margin % of 10.76% is 273% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Akdital and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Akdital's current Net Margin % is 10.76%, which is 27% above median its own 10-year median of 8.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akdital stock overvalued right now?
Based on GuruFocus' analysis, Akdital (CAS:AKT) is currently considered Possible Value Trap. The stock's GF Value™ is MAD2,083.49, compared to a current price of MAD1,174.00 — trading 43.7% below its estimated fair value. The current Net Margin % is 10.76%, which is 27% above median its 10-year median of 8.47 and 273% above the Healthcare Providers & Services industry median of 2.89. Akdital's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Akdital (CAS:AKT), the current Net Margin % is 10.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Akdital (CAS:AKT) Overvalued in 2026?
Based on GuruFocus' analysis, Akdital stock appears to be undervalued.
The current stock price of MAD1,174.00 is trading 43.7% below its estimated GF Value™ of MAD2,083.49.
GuruFocus considers Akdital to be Possible Value Trap.
Key valuation signals for CAS:AKT:
Net Margin %: 10.76% (27% above median its 10-year median of 8.47)
GF Value™: MAD2,083.49 vs. price of MAD1,174.00 (43.7% below fair value)
Industry Position: 273% above the Healthcare Providers & Services median (#150 of 668)
No single metric tells the full story. See the CAS:AKT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.
84GF Score
Get the complete analysis for CAS:AKT
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAS:AKT has been successfully added to your 
